The Council of the Queensland Institute of Medical Research
发明人:
Michelle Wykes
申请号：
US16324857
公开号：
US20190389929A1
申请日:
2016.08.11
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Disclosed are compounds for use in modulating immune responses. More particularly, the present invention discloses oligomeric forms of PD-L2 for use in modulating Th1 immune responses. The compounds of the present invention find utility in a range of Th1-mediated disorders including pathogenic infections and hyperproliferative disorders.
